In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US GPOs (group purchasing organisations): back to the drawing board if self-regulation "not working"

This article was originally published in Clinica

Executive Summary

The US group purchasing organisations (GPOs) are facing new restrictions, including loss of their coveted safe harbour from anti-kickback laws, if Congress concludes that their efforts at self-policing to ensure competition have not worked.

You may also be interested in...



Vous Vitamin Expands Exposure For Personalized Line Through Higi’s Kiosks In Grocery Stores

Vous Vitamin promotes personalized vitamin line through Higi Smart Health Stations in Giant Eagle grocery stores, largely in the Midwest. The kiosks offer five-minute health and wellness surveys and provide results consumer can use to order their vitamin online.

Heads Of HHS, FDA Outline Biden's Budget Proposals To US Congress

US President Joe Biden’s proposed budget for fiscal 2022 allocates $133.7bn for HHS, a 23% increase for the department from fiscal 2021; the administration is also asking for $6.5bn for the FDA, an 8% increase from the agency’s current budget.

WTO Chief: Pharma Needs To 'Lift The Veil Of Opaqueness' In COVID-19 Vaccine Contracts

WTO director general says pharma could have done more on voluntary licensing for COVID-19 vaccines and also calls for better transparency of pricing and contracts to ensure “a level playing field” when it comes to saving lives.

Topics

UsernamePublicRestriction

Register

MT051182

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel